Revolution Medicines Inc (RVMD) FY2025Q3 Earning Prediction

11/05 05:00:00

After Hours

Revolution Medicines Inc (RVMD) is set to release its earnings performance on 11/05 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 1.49M and an earnings per share (EPS) of -1.39 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueMISS

1.49M

0.00

-100.00%

EPSMISS

-1.39

-1.61

-15.83%

AI Summary

Report

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

RVMD Transcript

Revolution Medicines, Inc. (RVMD) Presents at Jefferies London Healthcare Conference 2025 Transcript

Neutral11-18

Revolution Medicines, Inc. (RVMD) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript

Neutral11-11

Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call Transcript

Unknown11-5

The earnings call presents a mixed sentiment. The company's financial outlook shows a significant projected net loss, which is negative. However, there is strong product development with multiple trials underway, a positive partnership with Royalty Pharma, and potential for new market opportunities. The Q&A section highlights some uncertainties, such as unclear responses on trial event rates and efficacy thresholds, which dampen the overall sentiment. Given these mixed signals, a neutral stock price movement is expected over the next two weeks.

Revolution Medicines, Inc. (RVMD) Q2 2025 Earnings Call Transcript

Unknown8-7

The earnings call summary and Q&A indicate mixed sentiments. Financial performance shows increased R&D expenses and projected losses, but a strong cash position. Product development is promising with ongoing trials and strategic collaborations. However, lack of specific regulatory updates and unclear management responses raise uncertainties. No new partnerships or shareholder return plans were announced. Overall, the sentiment is balanced with positive developments in product pipeline offset by financial and strategic uncertainties, leading to a neutral prediction.

RVMD Slides

Revolution Medicines August 2025 slides: advancing RAS inhibitor pipeline with promising data

2025-08-06

RVMD Report

Revolution Medicines, Inc. 10-Q

10-Q

2024-08-07

Revolution Medicines, Inc. 10-Q

10-Q

2024-05-08

Revolution Medicines, Inc. 10-K

10-K

2024-02-26

Revolution Medicines, Inc. 10-Q

10-Q

2023-11-06

Frequently Asked Questions

What is the Revolution Medicines Inc FY2025Q3 Earnings Release Date and Time?

Revolution Medicines Inc (RVMD) is scheduled to release its FY2025Q3 earnings report onNov 5, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Revolution Medicines Inc FY2025Q3 Revenue and EPS?

Analysts' consensus predicts 1.49M in revenue and an EPS of -1.39 for Revolution Medicines Inc's FY2025Q3.

What Does Intellectia's AI Predict for Revolution Medicines Inc FY2025Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forRevolution Medicines Inc's FY2025Q3 earnings, with a prediction date of Nov 5, 2025. Revolution Medicines Inc

How Can I Use This Earnings Prediction to Trade RVMD Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 5, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Revolution Medicines Inc FY2025Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!